HEALTHFINANCIAL TIMES WORLD
Big pharma warns Germany’s attempts to curb drug prices will backfire
Big pharma has warned that attempts by Germany to curb drug prices may backfire. Conversely, a government source stated that implementing higher mandatory discounts for insurers is predicted to save €12bn by 2030.
Mentioned
Related Signal
Adjacent reporting
- STAT+: Pharmalittle: We’re reading about bigger drug discounts in Germany, drugmakers embracing secrecy, and more
- STAT+: A political contest in the U.K. could shake up drug pricing
- STAT+: As the U.S. looks on, European countries feel growing pressure on drug prices
- Eli Lilly and Bayer hit out at Germany’s spending on new medicines
- STAT+: Pharmalittle: We’re reading about U.S. pressuring Germany on drug prices, FDA upheaval and biotech clinical trials, and more